Literature DB >> 11870635

Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.

Valli De Re1, Salvatore De Vita, Daniela Gasparotto, Alessandra Marzotto, Antonino Carbone, Gianfranco Ferraccioli, Mauro Boiocchi.   

Abstract

Sjögren's syndrome (SS) represents a pathological model of the evolution from polyclonal B lymphocyte activation to oligoclonal/monoclonal B cell expansion, which may culminate in the development of a malignant lymphoproliferative disease. The different phases of this process are usually marked by the appearance of antigen-driven activated B cell clones, which are commonly IgM-positive and with rheumatoid factor (RF) activity. However, the agent(s) able to trigger B cell proliferation is still unknown. A similar pathogenetic mechanism exist in mixed cryoglobulinemia, another autoimmune disease that often evolves to non-Hodgkin's lymphoma (NHL) and in which hepatitis C virus (HCV) infection has been demonstrated to play an etiopathogenetic role. In the present study, we cloned and sequenced the antigen receptor (IgR) variable region genes of SS-associated monoclonal non-neoplastic lymphoproliferations and compared them with those of our previous reported HCV-associated NHL, to derive clues on the antigen(s) that sustains SS. The results obtained showed remarkable homologies between the antigen combinatory regions of the IgR expressed by both diseases. These homologies concern: a) the specific combinations of heavy and light variable region genes; b) the limited length of complementarity-determining regions (CDR3); c) the homology with antibodies with RF activity; d)the amino acid sequences of CDR3 in which common somatic mutations are present that possibly determine the antigen-binding specificity. In conclusion, although there are significant differences between SS and HCV-associated lymphoproliferative diseases, they share many molecular characteristics, which suggest an immunological cross-reactivity or molecular mimicry among the agents that underlie these disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870635     DOI: 10.1002/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.

Authors:  Daxing Zhu; Chen Lossos; Jennifer R Chapman-Fredricks; Izidore S Lossos
Journal:  Am J Hematol       Date:  2013-03-28       Impact factor: 10.047

3.  Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity.

Authors:  Mitsunori Shiroishi; Yuji Ito; Kenta Shimokawa; Jae Man Lee; Takahiro Kusakabe; Tadashi Ueda
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

4.  Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement.

Authors:  M Tucci; C Quatraro; F Silvestris
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 5.  Restricted, canonical, stereotyped and convergent immunoglobulin responses.

Authors:  Carole J Henry Dunand; Patrick C Wilson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

Review 6.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

7.  Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1.

Authors:  Miroslaw K Gorny; Xiao-Hong Wang; Constance Williams; Barbara Volsky; Kathy Revesz; Bradley Witover; Sherri Burda; Mateusz Urbanski; Phillipe Nyambi; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner; Arthur Nadas
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

Review 8.  Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

Authors:  Elena Muraro; Debora Martorelli; Riccardo Dolcetti
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

Review 9.  Structural Basis of a Conventional Recognition Mode of IGHV1-69 Rheumatoid Factors.

Authors:  Mitsunori Shiroishi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome.

Authors:  L Dong; Y Masaki; T Takegami; Z-X Jin; C-R Huang; T Fukushima; T Sawaki; T Kawanami; T Saeki; K Kitagawa; S Sugai; T Okazaki; Y Hirose; H Umehara
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.